A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Intravenous Methylnaltrexone (MOA-728) for the Treatment of Post Operative Ileus.
Sponsor study identifier
interventional
495
9 countries
91
Study Start
December 2006
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
November 2007
Actual (reported)Primary Objective: In subjects who have undergone segmental colectomy, the time between the end of surgery and first bowel movement is significantly shorter with the investigational MOA-728 regimen than with a placebo regimen.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 2007
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 11, 2006
Actual (reported)October 13, 2006
Actual (reported)December 2006
Date type not reportedThis date has not been verified as actual or estimated.
November 2007
Actual (reported)Primary Objective: In subjects who have undergone segmental colectomy, the time between the end of surgery and first bowel movement is significantly shorter with the MOA-728 regimen than with a placebo regimen.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Mobile, Alabama, 36617, United States
Fort Smith, Arkansas, 72901, United States
Chula Vista, California, 92114, United States
Colton, California, 92324, United States
Los Angeles, California, 90033, United States
Oceanside, California, 92056, United States
Palo Alto, California, 94304, United States
Yu CS, Chun HK, Stambler N, Carpenito J, Schulman S, Tzanis E, Randazzo B. Safety and efficacy of methylnaltrexone in shortening the duration of postoperative ileus following segmental colectomy: results of two randomized, placebo-controlled phase 3 trials. Dis Colon Rectum. 2011 May;54(5):570-8. doi: 10.1007/DCR.0b013e3182092bde.
Jeff Cohn
Bausch Health Americas, Inc.
First Submitted
October 11, 2006
First Posted
October 13, 2006
Study Start
December 2006
Date type not reportedThis date has not been verified as actual or estimated.
Study Completion
November 2007
Actual (reported)Contact the study team to confirm eligibility.
San Jose, California, 95124, United States
Torrance, California, 90509, United States
Denver, Colorado, 80262, United States
Washington D.C., District of Columbia, 20007, United States
Bay Minette, Florida, 36507, United States
Jacksonville, Florida, 322224, United States
Melbourne, Florida, 32901, United States
Naples, Florida, 34119, United States
St. Petersburg, Florida, 33701, United States
Vero Beach, Florida, 32960, United States
Weston, Florida, 33331, United States
Atlanta, Georgia, 30303, United States
Atlanta, Georgia, 30342, United States
Marietta, Georgia, 30060, United States
Chicago, Illinois, 60611, United States
Chicago, Illinois, 60612, United States
Naperville, Illinois, 60540, United States
Park Ridge, Illinois, 60068, United States
Kansas City, Kansas, 66160, United States
Lexington, Kentucky, 40536, United States
New Orleans, Louisiana, 70121, United States
Hagerstown, Maryland, 21740, United States
Boston, Massachusetts, 02135, United States
Saint Paul, Minnesota, 55104, United States
Saint Paul, Minnesota, 55114, United States
Albany, New York, 12208, United States
Kingston, New York, 12401, United States
New York, New York, 10016, United States
New York, New York, 10029, United States
Syracuse, New York, 13210, United States
Chapel Hill, North Carolina, 27599, United States
Cleveland, Ohio, 44109, United States
Columbus, Ohio, 43210, United States
Zanesville, Ohio, 43701, United States
Oklahoma City, Oklahoma, 73104, United States
Bend, Oregon, 97701, United States
Portland, Oregon, 97239, United States
Danville, Pennsylvania, 17822, United States
Hershey, Pennsylvania, 17033, United States
Philadelphia, Pennsylvania, 19104, United States
Pittsburgh, Pennsylvania, 15213, United States
Wilkes-Barre, Pennsylvania, 18711, United States
Pawtucket, Rhode Island, 02860, United States
Providence, Rhode Island, 02903, United States
Memphis, Tennessee, 38103, United States
Nashville, Tennessee, 37232, United States
Fort Worth, Texas, 76104, United States
Fort Worth, Texas, 76107, United States
San Antonio, Texas, 78212, United States
Charlottesville, Virginia, 22908, United States
Norfolk, Virginia, 23507, United States
Winchester, Virginia, 22601, United States
Camperdown, New South Wales, 2050, Australia
Elizabeth Vale, South Australia, 5112, Australia
Woodville South, South Australia, 5011, Australia
Berlin, 13353, Germany
Halle, 06097, Germany
Heidelberg, 69120, Germany
München, 80336, Germany
Budapest, 1125, Hungary
Győr, 9024, Hungary
Pécs, 7624, Hungary
Székesfehérvár, 8000, Hungary
Osio Sotto, Zingonia, 24040, Italy
Bologna, 40138, Italy
Ferrara, 44100, Italy
Genova, 16132, Italy
Monza, 20052, Italy
Padova, 35128, Italy
Roma, 00168, Italy
Katowice, 40-752, Poland
Krakow, 31-202, Poland
Lodz, 91-425, Poland
Poznan, 60-355, Poland
Bucharest, 014461, Romania
Bucharest, 020475, Romania
Bucharest, 042122, Romania
Bucharest, 050098, Romania
Beograd, 11000, Serbia and Montenegro
Pretoria, Gauteng, 0084, South Africa
Pretoria, Gauteng, 0181, South Africa
Pietermaritzburg, KwaZulu-Natal, 3201, South Africa
Cape Town, Western Cape, 7580, South Africa
Seoul, 135-710, South Korea
Seoul, 138-736, South Korea
Last Updated
November 25, 2019
Record last verified: 2019-11
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: